Oncolytics Biotech Files 6-K Report
Ticker: ONCY · Form: 6-K · Filed: May 9, 2024 · CIK: 1129928
| Field | Detail |
|---|---|
| Company | Oncolytics Biotech INC (ONCY) |
| Form Type | 6-K |
| Filed Date | May 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, foreign-private-issuer, sec-filing
Related Tickers: ONCY
TL;DR
ONCOLYTICS BIOTECH (ONCY) filed a 6-K, confirming its foreign private issuer status and Canadian base.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on May 9, 2024, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and operates in the Pharmaceutical Preparations sector. This filing is for the month of May 2024 and indicates they file annual reports under Form 20-F.
Why It Matters
This filing provides routine disclosure for foreign private issuers, informing investors about the company's reporting status and location.
Risk Assessment
Risk Level: low — This is a routine disclosure filing for a foreign private issuer and does not contain new material financial or operational information.
Key Numbers
- 001-38512 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer
- May 9, 2024 (date) — Filing Date
- Calgary, Alberta, Canada (location) — Company Headquarters
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Filing
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, for the month of May 2024.
Where is Oncolytics Biotech Inc. located?
Oncolytics Biotech Inc. is located at Suite 804, 322 11th Avenue SW, Calgary, Alberta, Canada T2R 0C5.
Does Oncolytics Biotech Inc. file annual reports under Form 20-F or 40-F?
The filing indicates that Oncolytics Biotech Inc. files annual reports under cover of Form 20-F.
What is the SIC code for Oncolytics Biotech Inc.?
The Standard Industrial Classification (SIC) code for Oncolytics Biotech Inc. is 2834, which corresponds to Pharmaceutical Preparations.
When was this Form 6-K filed?
This Form 6-K was filed on May 9, 2024.
Filing Stats: 334 words · 1 min read · ~1 pages · Grade level 17 · Accepted 2024-05-09 12:11:18
Filing Documents
- form6kgobletc5regclearance.htm (6-K) — 18KB
- gobletc5regclearance.htm (EX-99.1) — 32KB
- 0001129928-24-000033.txt ( ) — 50KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Oncolytics Biotech Inc. (Registrant) By s Kirk Look Date May 9, 2024 Kirk Look Chief Financial Officer